person

Maria Sole C.

Country
Italy
Department
Rheumatology Unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
92
Sites with multiple studies

Has run more than one trial at 92 of 188 partner sites.

Specializations

Rheumatology and autoimmune disease

Clinical research activity is centered in rheumatology, with strong involvement in inflammatory disorders that affect joints, skin, and systemic immune pathways.

  • Psoriatic arthritis
  • Hidradenitis suppurativa
  • Systemic inflammation
  • Immune-mediated disease

The therapeutic landscape includes conditions linked to chronic immune dysregulation and biologic treatment development in inflammatory disease.

Inflammatory bowel disease

Research involvement extends to major gastroenterology indications, especially chronic intestinal inflammation and symptom control in active disease.

  • Crohn’s disease
  • Ulcerative colitis
  • Bowel urgency
  • Transmural healing

This area reflects interest in therapies aimed at controlling intestinal inflammation, improving mucosal outcomes, and addressing persistent disease burden.

Neurology and neuroimmunology

Clinical trial activity includes neurological disorders with a pronounced focus on chronic immune-mediated and degenerative conditions.

  • Multiple sclerosis
  • Parkinson’s disease
  • Myasthenia gravis
  • Epilepsy

The therapeutic scope also includes treatment strategies for relapsing and progressive neurological disease, together with symptom-focused neurological care.

Dermatology and allergic disease

Research interests cover inflammatory skin disease, pruritic disorders, and immune-related dermatologic conditions requiring targeted therapy.

  • Plaque psoriasis
  • Atopic dermatitis
  • Prurigo nodularis
  • Chronic inducible urticaria

This domain includes both chronic inflammatory skin disease and allergic manifestations driven by immune activation.

Hematology and oncology

Trial activity also spans blood cancers and related marrow disorders, with emphasis on therapies for progressive and treatment-resistant disease.

  • Acute myeloid leukemia
  • Myelodysplastic syndromes
  • Chronic lymphocytic leukemia
  • Prostate cancer

The portfolio includes malignancies with hematologic and solid-tumor relevance, reflecting engagement in advanced therapeutic innovation across oncology.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.